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Background: Accumulation of amyloid β (Aβ) is one of the main hallmarks of Alzheimer’s
disease (AD). The enhancement of Aβ clearance may provide therapeutic means to
restrict AD pathology. The cellular responses to different forms of Aβ in monocytic cells
are poorly known. We aimed to study whether different forms of Aβ induce inflammatory
responses in monocytic phagocytes and how Aβ may affect monocytic cell survival and
function to retain phagocytosis in Aβ-laden environment.
Methods: Monocytic cells were differentiated from bone marrow hematopoietic stem
cells (HSC) in the presence of macrophage-colony stimulating factor. Monocytic
cells were stimulated with synthetic Aβ42 and intracellular calcium responses were
recorded with calcium imaging. The formation of reactive oxygen species (ROS),
secretion of cytokines and cell viability were also assessed. Finally, monocytic cells
were introduced to native Aβ deposits ex vivo and the cellular responses in terms of
cell viability, pro-inflammatory activation and phagocytosis were determined. The ability
of monocytic cells to phagocytose Aβ plaques was determined after intrahippocampal
transplantation in vivo.
Results: Freshly solubilized Aβ induced calcium oscillations, which persisted after
removal of the stimulus. After few hours of aggregation, Aβ was not able to induce
oscillations in monocytic cells. Instead, lipopolysaccharide (LPS) induced calcium
responses divergent from Aβ-induced response. Furthermore, while LPS induced
massive production of pro-inflammatory cytokines, neither synthetic Aβ species nor
native Aβ deposits were able to induce pro-inflammatory activation of monocytic
cells, contrary to primary microglia. Finally, monocytic cells retained their viability in the
Abbreviations: AD, Alzheimer’s disease; Aβ, Amyloid β; APdE9, human amyloid precursor protein APP695 Swedish
mutation and human presenilin-1 deletion in exon 9 mouse line; ATP, adenosine triphosphate; CNS, central nervous
system; fAβ, fibrillar Amyloid β; GFP, green fluorescent protein; ELISA, enzyme-linked immunosorbent assay;
HSC, hematopoietic stem cell; IL, interleukin; LPS, lipopolysaccharide; MCP-1, monocyte chemoattractant protein-1;
MCSF, macrophage colony stimulating factor; NO, nitric oxide; ROS, reactive oxygen species; sAβ, soluble Amyloid β;
TNFα, tumor necrosis factor α.
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presence of Aβ and exhibited phagocytic activity towards native fibrillar Aβ deposits and
congophilic Aβ plaques.
Conclusion: Monocytic cells carry diverse cellular responses to Aβ and inflammatory
stimulus LPS. Even though Aβ species cause specific responses in calcium signaling,
they completely lack the ability to induce pro-inflammatory phenotype of monocytic cells.
Monocytes retain their viability and function in Aβ-laden brain.
Keywords: Alzheimer’s disease, amyloid beta, bone marrow, calcium, cytokines, hematopoietic stem cells,
monocytes, phagocytosis
INTRODUCTION
Microglia, the immune cells in the central nervous system (CNS),
actively survey their microenvironment in the brain parenchyma.
After injury, microglia motility switches from untargeted to
targeted movement towards the lesion site (Nimmerjahn et al.,
2005). Microglia are thus important regulators of normal
brain physiology and also crucial mediators of pathological
processes in the CNS (Kettenmann et al., 2011). In Alzheimer’s
disease (AD), microglia accumulate around amyloid β (Aβ)
deposits, interact with Aβ and possibly contribute to Aβ
removal. Many studies indicate that microglia may be renewed
from peripheral monocytic cells. The extent and conditions of
peripheral monocytic cell migration in AD, however, remain
controversial (Malm et al., 2005; Simard et al., 2006; Ajami
et al., 2007; Mildner et al., 2007, 2011; Lebson et al., 2010;
Hao et al., 2011; Naert and Rivest, 2012; Koronyo et al.,
2015). Monocytes, however, may also participate in Aβ removal
by not entering the brain parenchyma (Michaud et al.,
2013).
The hallmarks of AD include accumulation of Aβ in the brain
regions that serve cognition and memory. In the amyloidogenic
pathway, amyloid precursor protein is cleaved into Aβ peptides
Aβ40 and Aβ42, the latter being more prone to aggregation
(De Strooper, 2010). Monomeric Aβ spontaneously aggregates
into oligomers and high-molecular weight oligomers, which
further aggregate to form insoluble fibrils and eventually,
Aβ plaques. Aβ-mediated neurotoxicity is dependent on Aβ
aggregation state from which Aβ oligomers are the most
neurotoxic as reviewed in Aguzzi and O’Connor (2010), and
De Strooper (2010). Furthermore, Aβ signaling and Aβ removal
by astrocytes and microglia are also dependent on the Aβ
aggregation state (D’Andrea et al., 2004; Mandrekar et al., 2009;
Michelucci et al., 2009; Sondag et al., 2009; Nielsen et al.,
2010).
The late-onset AD is associated with a 30% decrease in the
clearance of Aβ (Mawuenyega et al., 2010) which may eventually
lead to accumulation of Aβ and disturbance of neuronal
homeostasis. In genome wide analysis, many susceptibility
loci associated with microglial and myeloid cell function have
been identified for late-onset AD (Guerreiro et al., 2013;
Lambert et al., 2013; Benitez et al., 2014; Ramanan et al.,
2015). Since proper Aβ clearance may play a crucial role
in the development of AD, the mechanisms of Aβ clearance
are under intensive investigation also in terms of therapeutic
aspects. The migration of monocytic cells may require specific
factors and the infiltration of these cells into the brain in
sufficient quantities may be a challenge. We have provided a
method which allows genetic manipulation of hematopoietic
stem cells (HSC) and their subsequent in vitro differentiation
into phagocytic monocytic cells (Magga et al., 2012). By
utilizing these cells as a model, we investigated the cellular
responses of monocytic cells into different species of Aβ in
terms of cellular signaling, cytokine production, reactive oxygen
species (ROS) and nitric oxide (NO) production, phagocytosis
of Aβ and cell viability. We demonstrate that opposite to
inflammatory stimulus induced by lipopolysaccharide (LPS),
Aβ species completely lack pro-inflammatory activation of
monocytic cells, contrary to that observed in primary microglia.
Instead, freshly solubilized Aβ induces calcium oscillations and a
minor production of anti-inflammatory cytokine interleukin-10
(IL-10). In addition, monocytic cells retain their function and
characteristics as phagocytic cells in the brain with native Aβ
plaques.
MATERIALS AND METHODS
Cell Culture
Monocytic cells were cultivated as described before Magga
et al. (2012). Briefly, bone marrow was isolated from 6- to 8-
week-old C57BL mice. When needed to obtain greater amount
of HSCs, or to obtain HSCs from mice over 8-weeks-old,
adult mice were treated s.c. with a single dose of granulocyte
colony stimulating factor 500 µg/kg (Pegfilgrastim, Neulasta,
Amgen, diluted in sterile 0.15 M sodium acetate, pH adjusted
to 7.4. with acetic acid) 3–4 days prior to the sacrifice
to mobilize HSCs. Then, bone marrow mononuclear cells
were isolated by gradient centrifugation with Ficoll paque
(GE Healthcare) and HSCs were isolated by immunomagnetic
cell separation using CD117 mouse HSC positive selection
kit (EasySep, StemCell Technologies). CD117+ cells were
plated at 100,000 cells/cm2 and proliferated in serum-free
conditions in a humidified atmosphere at 37◦C in 5% CO2
as described (Malm et al., 2008). Non-adherent cells were
replated every 2 days when half of the medium was refreshed.
For differentiation, non-adherent cells were collected and
plated at 100,000 cells/cm2 in Iscove’s modified Dulbecco’s
medium (IMDM) in the presence of low endotoxin serum,
L-glutamine, penicillin-streptomycin (all products from Gibco,
Thermo Fisher Scientific, Waltham, MA, USA), 100 µM
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β-mercaptoethanol (Sigma) and 10 ng/ml macrophage colony
stimulating factor (MCSF; R&D Systems, Minneapolis, MN,
USA). After differentiation, cells were collected in PBS when
needed.
Primary mouse postnatal day P0-P1 microglia cultures were
prepared from cortices and hippocampi and cultivated as a
mixed astrocyte/microglia culture as described before Magga
et al. (2012). Nonadherent microglia present above the astrocyte
layer were collected by shaking the plates 10–15 min at
120 rpm at 37◦C and collection of supernatant. Adherent
microglia below the astrocyte layer were collected by removal
of astrocyte layer with mild trypsinization and collection of
remaining microglia from bottom of the flask with repeated
pipetting in PBS, as described earlier (Magga et al., 2012). After
collection and when plated as microglia culture, both cell types
adhered to surface. Microglia were cultivated in IMDM, 10%
low endotoxin serum, L-glutamine, penicillin-streptomycin (all
products from Gibco, Thermo Fisher Scientific, Waltham, MA,
USA).
Aβ Preparation
Aβ species were prepared as described before Magga et al.
(2010). Aβ42 (American Peptide) was dissolved into a stock
solution of 1 mg/ml in sterile water (soluble Aβ termed as
‘‘sAβ’’). To obtain fully fibrillized Aβ (termed as ‘‘fAβ’’), the
dissolved peptide was incubated at 37◦C for a week. We have
previously analyzed these Aβ preparations with immunoblotting
for human Aβ (clone 6E10, Signet, Covance) after cross-
linking the samples with glutaraldehyde (Sigma; Kanninen et al.,
2008; Magga et al., 2010). Immediately after dissolving the
peptide, the Aβ42 peptide preparation contained monomers,
dimers, various forms of oligomers and large high molecular
weight aggregates. Within time, the amount of low molecular
weight forms decreased, as analyzed 24 h to 48 h after
solubilization. In in vitro studies, we used the concentration of
Aβ42 preparation which has been neurotoxic in our previous
studies in primary hippocampal neurons and neural stem cells,
including dose-response assays for cell viability and neural stem
cell migration (Kanninen et al., 2008; Karkkainen et al., 2012;
Kärkkäinen et al., 2014).
To obtain native Aβ deposits (termed as ‘‘native Aβ’’),
brains were excised from aged APdE9 mice (Jankowsky
et al., 2004) overexpressing human amyloid precursor protein
APP695 Swedish mutation and human presenilin-1 deletion in
exon 9 (dE9) genes. Brains were frozen on dry ice and processed
as previously described (Pihlaja et al., 2008; Magga et al., 2010).
Briefly, cryostat-cut 10-µm-thick sagittal brain sections were
mounted on glass coverslips and transferred onto 48-well cell
culture plates and stored at −20◦C until used. Brain sections
were thawed shortly prior to the use and rehydrated with
cell culture medium before application of cells on top of the
sections.
Calcium Imaging
Cells were differentiated for 2 days, and then replated in
differentiation medium onto 25-mm glass coverslips (Merck) for
another 3 days. Calcium imaging was performed as described
previously (Magga et al., 2006). Briefly, cells were loaded with
4 µM fura-2 acetoxymethyl ester (Molecular Probes) at 37◦C for
20 min in HEPES-buffered medium (137 mM NaCl, 5 mM KCl,
0.44 mM KH2PO4, 4.2 mM NaHCO3, 10 mM glucose, 20 mM
HEPES, 1 mM probenecid, 1 mM CaCl2 and 1.2 mM MgCl2
(all reagents from Sigma), pH 7.4). The coverslip was attached
to the bottom of a 37◦C thermostated perfusion chamber
and stimulants were applied by perfusion in HEPES-buffered
medium. The cells were excited by alternating 340 and 380 nm
UV light with a filter exchange in the control of an InCyt2 system
(Intracellular Imaging) and emission was measured through a
dichroic mirror and a 510 nm barrier filter with a Cohu CCD
camera. A new ratio image (340/380 nm) was collected every
second. Primary microglia were applied to calcium imaging
2–3 days after their plating to coverslips. Microglia were
labeled with 2 µM fluo-3 acetoxymethyl ester and imaged
with TillVision equipped with rapid shifting monochromator
Polychrom V with wavelength 488 nm (TILL Photonics GmbH)
and perfused with HEPES-buffered medium. Cells were viewed
via Olympus IX-70 microscope with specific filter using 10×
objective. Images were collected using Sensicam VGA digital
camera (PCO AG) at sampling frequency of two frames
per second. The data were analyzed with Origin (OriginLab) for
quantification of responsive cells and their peak amplitude. The
cell was determined viable if it responded to any of the stimuli
used.
Cytokine Assay
After 2 days of differentiation, cells were replated onto 24-well
plate at 70,000 cells/cm2 for another 2 days. Cells were cultivated
in differentiation medium and treated with 50 ng/ml LPS (from
Escherichia Coli, serotype O111:B4, Sigma) or 20 µM sAβ or
20 µM fAβ. After 24 h of incubation, media were collected,
centrifuged to remove any cell debris, and the supernatant was
frozen at−70◦C. Cytokine concentrations were determined with
tumor necrosis factor α (TNFα) enzyme-linked immunosorbent
assay (ELISA; R&D Systems, Minneapolis, MN, USA). Cytokine
production was also determined from cell culture medium
collected after 100 ng/ml LPS, 10 µM sAβ or 10 µM fAβ
stimulation. Cytokines were analyzed with cytometric bead
array mouse inflammation kit (BD Biosciences) according to
manufacturer’s instructions. Primary microglia were treated
with stimulants 2 days after their separation from astrocyte
co-culture. Cytokine production was analyzed from medium
with cytometric bead array kit.
Nitric Oxide Assay
After 2 days of differentiation, cells were replated onto 96-well
plate at 100,000 cells/cm2 for another day. Cells were cultivated
in phenol red–free differentiation medium and treated with
100 ng/ml LPS, 10 µM sAβ, 10 µM fAβ or 300 µM paraquat
(Sigma). After 24 h of incubation, media were collected and
mixed with an equal volume of Griess reagent (2% phosphoric
acid, 1% sulfanilamide, 0.1% naphthylethylene dihydrochloride;
Sigma), incubated for 10 min. Absorbance was measured at
540 nmwith a multiscan reader. Sodium nitrite (Sigma) was used
as a standard.
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ROS Assay
After 2 days of differentiation, cells were replated onto 96-well
plate at 100,000 cells/cm2 for another day. Cells were cultivated
in differentiation medium and treated with 100 ng/ml LPS,
10 µM sAβ, 10 µM fAβ or 300 µM paraquat (Sigma).
After 4 h of incubation, medium was removed and replaced
with ROS assay buffer (HBSS, 15 mM HEPES, 5.5 mM
glucose and 1.8 mM CaCl2, Sigma) supplemented with 20 µM
2’7’-dichlorofluorescein (Sigma) and incubated at 37◦C for
30 min. Thereafter, cells were washed once with ROS assay buffer
and ROS production was measured with excitation 485 nm,
emission 535 nm with multi-label microplate reader (Victor
Wallac).
Cell Viability Assay
After 2 days of differentiation, cells were replated onto 48-well
plate as 100,000 cells/cm2 for another day. Cells were cultivated
in differentiation medium and treated with 100 ng/ml LPS,
10 µM sAβ, 10 µM fAβ or 300 µM paraquat (Sigma). After
24 h of incubation, 10 µM resazurin (Sigma) was applied and
incubated for 4 h. Medium samples were collected into a 96-well
plate and measured by excitation at 544 nm and emission at
590 nm on a multiplate reader (Victor Wallac).
Cell Migration Assay
Cell migration was analyzed by live cell imaging system Cell-
IQ, equipped with a phase-contrast microscope and a camera
(Chip-Man Technologies, Tampere, Finland). Monocytic cells
growing on a 48-well plate were left untreated or treated with
either 100 ng/ml LPS, 10 µM sAβ or 10 µM fAβ and cultured in
the Cell-IQ incubator for 12 h. Eight replicate wells were analyzed
per treatment. Time-lapse images were taken every 15 min and
the trajectory and the speed of cell migration were analyzed
for 20 cells per well with Cell-IQ Analyzer software. The total
number of analyzed cells per group is 160.
Flow Cytometry
Cells were counted and stained as described (Malm et al., 2005).
Briefly, cells were fixed with 4% paraformaldehyde (Sigma) for
20 min at room temperature and then permeabilized with 0.05%
saponin (Sigma) and stained with CD68 (Serotec). A minimum
of 10,000 events were acquired on FACSCalibur flow cytometer
equipped with a 488 laser (BD Biosciences). Data analysis was
performed using Cellquest Pro software (BD Biosciences).
Ex Vivo Aβ Degradation Assay
The cells were incubated in differentiation medium on top of
brain sections obtained from aged APdE9 mice containing native
Aβ deposits. After 5 days of incubation, Aβ quantification was
performed with Aβ ELISA or pan-Aβ immunostaining (both
from Biosource) as described (Malm et al., 2008).
Transplantation
Intrahippocampal transplantation was performed as described
(Magga et al., 2012). Briefly, 2-year-old transgenic APdE9 mice
and their non-transgenic littermates were anesthetized with
isoflurane (Baxter) and placed in a stereotaxis apparatus.
Monocytic cells (300,000 in 1 µl of HBSS, 2% fetal bovine
serum (both from Gibco, Thermo Fisher Scientific, Waltham,
MA, USA)) were injected with a Hamilton syringe into the
right hippocampus and the same amount of vehicle was injected
into the left hippocampus according to following coordinates:
±0.25 mm medial/lateral, 0.27 mm anterior/posterior, 0.25 mm
dorsal/ventral from bregma. Brains were excised 4 days
post-transplantation and processed as described (Magga et al.,
2012). All animal experiments were conducted according to the
national regulations for the use and welfare of laboratory animals
and approved by the Animal Experiment Committee in State
Provincial Office of Southern Finland.
Histological Analysis
Histological analysis was performed as described (Malm et al.,
2005). Briefly, 20-µm coronal sections were stained with
Anti-pan Aβ (rabbit polyclonal, Biosource) or Congo red
(Sigma), which was applied as 0.2% Congo red in 0.01% NaOH,
saturated NaCl/EtOH solution. Stainings were visualized with
fluorescence or light microscope and immunoreactive area was
quantified using Image Pro Plus software (Media Cybernetics)
from the hippocampal region.
Statistical Analysis
The data are expressed as mean ± standard deviation and
analyzed with SPSS software using Student’s t-test or one-way
analysis of variance when appropriate, followed by Tukey’s
post hoc test. The occurrence of calcium responsiveness was
evaluated with Fisher’s exact test. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p< 0.001.
RESULTS
Inflammatory Stimulus and Growth Factor
Induce Different Calcium Responses in
Monocytic Cells
Monocytic cells were differentiated from HSCs in the presence
of MCSF. After a few days of differentiation, these cells
represent phagocytic activity as well as response to inflammatory
stimulus LPS in terms of increased cytokine production and
NO release (Magga et al., 2012). Herein, we aimed to further
characterize their response to specific inflammatory stimulus
induced by Aβ. First, we exposedmonocytic cells to a well-known
pro-inflammatory stimulus LPS and measured cellular calcium
responses by intracellular calcium imaging. After loading the
cells with a fluorescent calcium indicator Fura-2, the cells
were perfused with a stimulant and individual cells were
imaged for determination of intracellular calcium response.
LPS induced a minor elevation in intracellular calcium in
monocytic cells. This elevation was either a transient elevation
(in 46% of the responsive cells) or slow elevation on the
in intracellular calcium level (in 54% of the responsive cells;
Figures 1A,B). Both the transient elevation and the low
elevation in intracellular calcium level were responses of low
amplitude (Figures 1A,B). This minor LPS-induced calcium
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FIGURE 1 | Pro-inflammatory stimulus lipopolysaccharide (LPS) and growth factor macrophage colony stimulating factor (MCSF) induce distinct
calcium responses in monocytic cells. Monocytic cells were differentiated from hematopoietic stem cells (HSC) in the presence of MCSF for 5 days.
Pro-inflammatory stimulus LPS induced a minor elevation in intracellular calcium, either transient (A, left panel, marked with black) or slow elevation of the intracellular
calcium level (A, right panel, marked with gray). Majority of cells responded to LPS (B, n = 55), but the amplitudes of LPS-induced responses were low (B, n = 34).
Growth factor MCSF induced an oscillatory calcium response (C). LPS stimulation reduced subsequent MSCF-induced calcium response (D), both the number of
MCSF-responsive cells (p < 0.001, n = 71) and the amplitude of MCSF-induced calcium response (p < 0.05, n = 54). As comparison, LPS had no effect on
adenosine triphosphate (ATP)-induced elevation of intracellular calcium, used as an internal control (E). ∗p < 0.05, ∗∗∗p < 0.001.
elevation was accompanied with activation of cell mobility.
Monocytic cells were static, but within minutes after LPS
application they changed into exploring cells. LPS induced
monocytic cell protrusions to elongate to random direction in
a non-organized manner (experimental observation, data not
shown).
MCSF is a differentiation and growth factor for monocytes
(Ginhoux and Jung, 2014). When stimulated with a recombinant
MCSF, monocytic cells responded with a transient calcium
elevation or with an oscillatory calcium response (Figure 1C). As
seen in Figure 1A, LPS induced only a minor calcium response
in monocytic cells. LPS stimulation, however, reduced both
the occurrence and amplitude of subsequent MCSF-induced
calcium response either when LPS was inducing a calcium
response of its own or when LPS induced no detectable elevation
in intracellular calcium at all (Figure 1D). As comparison,
LPS had no effect on adenosine triphosphate (ATP)-induced
elevation of intracellular calcium (Figure 1E). This indicates
that inflammatory stimulus may specifically interfere with
monocytic growth factor signaling while leaving at least some
other cellular signaling pathways intact. We have previously
shown that omission of MCSF reduces monocytic cell viability
but if stimulated with LPS, the cell survival increases back
to normal level (Magga et al., 2012). LPS and MCSF may
thus induce some competitive cellular pathways leading to
enhancement of monocytic proliferation/survival. On the other
hand, ATP serves as a potential danger signal in CNS and
activates microglia. LPS and ATP-mediated signaling may both
induce similar types of signals, i.e., microglial motility and the
release of various biologically active substances, such as cytokines
and inflammatory proteins (Kettenmann et al., 2011). Since
we did not observe an overlap in LPS and ATP signaling,
they probably utilize different calcium signaling pathways in
monocytic cells.
Soluble Aβ Induces Calcium Oscillations in
Monocytic Cells
Distinct from LPS-induced calcium response, freshly solubilized
Aβ (termed as sAβ) induced a pronounced transient calcium
response or, interestingly, an oscillatory calcium response
(Figure 2A). Calcium response to freshly solubilized Aβ was
detected in majority of cells while 90% of these responses were
oscillatory by nature, and the amplitude was far greater than
induced by LPS (Figures 2B,C). Surprisingly, the amplitude of
calcium response induced by Aβ decayed after the solubilization
event time-dependently (Figure 2B). Also, the occurrence
of calcium response decreased after the solubilization event
(Figure 2C). As a comparison, the occurrence of calcium
responses to ATP in the same cells remained constant and
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FIGURE 2 | Soluble amyloid β (Aβ) induces calcium oscillations in monocytic cells. Freshly solubilized soluble Aβ (sAβ) induced persistent oscillatory calcium
responses in monocytic cells (A). Both the amplitude (B) and the occurrence of calcium response (C) induced by sAβ decayed after the solubilization event
time-dependently (p < 0.001, n = 34). The oscillations induced by sAβ could persist even the maximum recording time, 30 min. As comparison, calcium responses
to ATP in the same cells remained constant (C, n = 38). Fibrillar Aβ (fAβ) induced only a minor calcium response, if any, in monocytic cells (D). Five representative
calcium imaging traces shown from microglia collected from astrocyte/microglia coculture above astrocyte layer, termed as nonadherent (E) and microglia collected
below astrocyte layer, termed as adherent (F), without (upper panels) and with sAβ treatment (lower panels). ATP was used as an intrinsic control. sAβ did not
increase basal calcium level in nonadherent (E, control n = 14, sAβ n = 17) or adherent microglia (F, control n = 16, sAβ n = 14). ∗∗∗p < 0.001.
did not decrease time-dependently (Figure 2C). Prefibrillized
Aβ (termed as fibrillar Aβ, fAβ) induced a small calcium
response (in 50% of the stimulated cells, with 1 340/380 ratio
value of 190) resembling the time-dependent decayed calcium
response of sAβ (Figure 2D). As seen in Figure 2A, calcium
oscillations induced by freshly solubilized Aβ persisted even
after removal of Aβ stimulus. Therefore, calcium responses
induced by MCSF could not be reliably determined after Aβ
stimulus since they were mainly covered by oscillatory calcium
responses induced by sAβ. Also, the magnitudes of ATP-induced
calcium responses could not be reliable determined since they
were partly masked by persistent oscillatory response induced
by sAβ. Aβ may utilize same calcium signaling pathways thus
underestimating the magnitude of ATP response. To be noted,
ATP did not induce oscillatory calcium signaling but calcium
transients.
To examine whether sAβ-induced calcium oscillations
occur in other mononuclear phagocytes, we performed
calcium imaging for primary microglia, collected from mixed
astrocyte/microglia culture as nonadherent microglia cells above
the astrocyte layer and as adherent microglia cells growing
below astrocyte layer. Microglia had less stable basal intracellular
calcium level (Figures 2E,F) compared to monocytic cells
(Figures 1C, 2A,D). Microglia produced spontaneous calcium
transients without stimulus (Figures 2E,F), which interfered
with further detection of possible sAβ-induced responses.
However, we did not detect a clear oscillatory pattern in
microglia (Figures 2E,F) similar to that observed in monocytic
cells. In addition, calcium levels were not further increased
after sAβ stimulus, compared to basal levels without stimulus
(Figures 2E,F). Both microglia types produced prominent
calcium response to ATP (Figures 2E,F), served as a control
stimulus. In general, it is very difficult to maintain microglia in
resting state in vitro; any change in their culture environment
tends to transform them into activated state. This may cause
difficulties in sensitive measurements as calcium signaling.
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To test whether sAβ-induced calcium oscillations could be
reduced with anti-inflammatory treatment, monocytic cells were
preincubated with neuroprotective and neuroinflammatory drug
minocycline (Tikka et al., 2001; Malm et al., 2008). One day or
immediate preincubation with minocycline (5 µM), however,
had no effect on sAβ-induced calcium oscillations (data not
shown). Taken together, the data suggest that sAβ induces
oscillatory, persistent calcium signaling in monocytic cells. We
next aimed to decipher how calcium responses induced by Aβ
affected monocytic cell activation and viability.
Aβ Species Induce Anti-Inflammatory but
No Proinflammatory Activation of
Monocytic Cells, Contrary To Primary
Microglia
Interestingly, sAβ induced a small, significant production of
anti-inflammatory cytokine IL-10 (p < 0.05, Figure 3A) which
was transient and decayed until 6 h incubation. There was no
significant production of IL-12 (active heterodimer IL-12p70) in
response to sAβ (p = 0.06, Figure 3B). Neither synthetic sAβ
nor fAβ caused any production of pro-inflammatory cytokines
IL-6 (Figure 3C) or TNFα (Figure 3D). Monocytic cells had high
production of monocyte chemoattractant protein-1 (MCP-1),
but it was not affected by sAβ (Figure 3E). LPS, on the other
hand, increased production of all aforementioned cytokines
(Figures 3A–E). Cytokine production did not, however, affect
cell migration (Figure 3F). Furthermore, when monocytic cells
were incubated on top of brain sections from APdE9 mice
containing substantial amount of native Aβ deposits as well as
inflammatory environment present in the AD mouse brain, no
TNFα production was observed (Figure 3G). Synthetic Aβ or
native Aβ deposits induced noNOproduction while LPS induced
a notable production of NO (Figure 3H). This is in line with
our previous results where we have shown these HSC-derived
monocytic cells to produce inflammatory cytokine TNFα and
release NO after inflammatory stimulation with LPS (Magga
et al., 2012).
In comparison, we also studied how Aβ species activate
primary microglia. Unlike monocytic cells, the production of
IL-10 and IL-12p70 cytokines in microglia remained under
detectable level. Aβ species did not induce any anti-inflammatory
cytokine production in microglia. LPS induced production of
IL-10 (42 ± 6 pg/ml in nonadherent, 33 ± 2 pg/ml in adherent
microglia, respectively) but no IL-12p70. sAβ did not produce
any inflammatory activation in microglia, but fAβ induced
production of proinflammatory cytokine TNFα in microglia
(Figures 3I,J). LPS increased production of IL-6, TNFα and
MCP-1 in microglia as expected (Figures 3I,J).
Aβ Does Not Induce ROS Production But
Affects Monocytic Cell Viability
Species-Dependently
Since sAβ induced calcium oscillations and anti-inflammatory
cytokine production but did not induce pro-inflammatory
cytokine or NO production, we further investigated whether Aβ
induces ROS production or affects monocytic cell viability. Aβ
did not induce ROS production while LPS induced a pronounced
production of ROS (Figure 4A). Nevertheless, fAβ treatment
triggered a slightly reduced cell viability (Figure 4B). Although
LPS induced pro-inflammatory activation and clear ROS
production, the cell viability was rather increased (Figure 4B).
We have previously demonstrated that HSC-derived monocytic
cell growth is greatly dependent on MCSF as a growth factor, or
on the inflammatory stimulus LPS (Magga et al., 2012).
Finally, we investigated how the persistent oscillatory
response of freshly solubilized sAβ (Figure 2A) affects monocytic
cell function. We stimulated the cells with freshly solubilized
sAβ for 1 h, then washed the cells and changed the medium to
exclude further stimulation with aggregating Aβ. When analyzed
24 h later, short stimulation with freshly solubilized sAβ, capable
of inducing persistent calcium oscillations (Figure 2A) was
not found to reduce cell viability (Figure 4C). While LPS
induced the classical ameboid phenotype, sAβ did not change cell
morphology into ameboid inflammatory phenotype (Figure 4D).
Taken together, sAβ did not induce pro-inflammatory cytokine,
NO or ROS production and did not affect cell viability but
induced a production of anti-inflammatory cytokine. This
finding suggests that the oscillatory calcium response induced by
freshly solubilized sAβ is not a detrimental stimulus tomonocytic
cells.
Monocytic Cells Retain Their
Characteristics as Phagocytic Cells
Towards Native Aβ Deposits Ex Vivo
To investigate the monocytic function in the presence of native
Aβ deposits, we cultivated the cells on top of brain sections
obtained from aged APdE9 and wild type mice. The environment
rich in native Aβ deposits did not affect cell viability (Figure 5A).
Monocytic cells retained also their characteristics as phagocytes.
This was evidenced by flow cytometry analysis that showed
no difference in the expression of lysosomal and phagocytosis
marker CD68 on cells incubated on top of brain sections
prepared from aged wild type or APdE9 mice (Figures 5B–D).
These findings are-in line with our previous report on the
potential of monocytic cells to internalize or clear Aβ in vitro,
ex vivo and in vivo (Magga et al., 2012). Furthermore, in the areas
of high rate of phagocytosis, monocytic cells tended to eventually
phagocytose both diffuse and hard Aβ plaques, leaving vascular
Aβ plaques intact (Figures 5E,F). In ex vivo assay, monocytic cells
are exposed to both insoluble and sAβ during cell attachment
and phagocytosis, the level of sAβ42 (19.1± 12.1 pg/ml) roughly
corresponding to concentrations of Aβ42 in human plasma.
Monocytic Cells Reduce Congophilic Aβ
Plaques In Vivo
Our previous studies have shown that intrahippocampally
transplanted monocytic cells survive well in APdE9 mouse
brain and reduce Aβ deposits as detected within pan-Aβ
immunoreactive area (Magga et al., 2012). In line with the
earlier study, transplanted monocytic cells detected by their
green fluorescent protein (GFP) fluorescence (Figure 6A) were
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FIGURE 3 | sAβ induces interleukin-10 (IL-10) production but no proinflammatory cytokine or nitric oxide (NO) production in monocytic cells.
Monocytic cells were stimulated with synthetic 10 µM sAβ or fAβ or 100 ng/ml LPS upto 6 h. Cytokine production was analyzed from cell culture medium with
cytometric bead array utilizing flow cytometry. SAβ induced a transient production of IL-10 (A, n = 4–8) but no significant production of IL-12 was detected
(B, n = 4–8). Aβ did not cause any production of pro-inflammatory cytokine IL-6 of Tumor necrosis factor α (TNFα) (C,D, n = 4–8). As an annotation, interferon-γ was
under detectable level in monocytic cells. While monocyte chemoattractant protein-1 (MCP-1) production in monocytic cells was high (E, n = 4–8), Aβ or LPS did not
affect cell migration as determined for 12 h (F, n = 8) when monitoring the cell trajectory length in automated cell culture and analysis system (Cell IQ). When
confirming proinflammatory cytokine production with ELISA, TNFα was neither produced if monocytic cells were incubated on top of brain sections from aged
APdE9 mice containing native Aβ deposits nor in the presence of synthetic Aβ (G, n = 4). Again, LPS (50 ng/ml) induced high production of TNFα (G, p < 0.001,
n = 6). Similarly, synthetic Aβ (n = 8) or native Aβ deposits (n = 4) did not induce NO production like LPS (H, p < 0.001, n = 8). Analyzed with cytometric bead array,
6 h incubation with fAβ induced production of TNFα in primary microglia (I,J, p < 0.001, n = 4). Interferon-γ, as well as IL-10 and IL-12 were under detectable levels
in microglia. LPS served as a positive control for cytokine production. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
observed in the hippocampus 4 days after transplantation. In
addition to reduction of diffuse Aβ plaques in the hippocampus
(Magga et al., 2012), transplanted monocytic cells also reduced
Congo red positive Aβ plaques in the areas occupied by the
cells (Figures 6B,C). When Aβ was quantified from the areas
devoid of transplanted cells, there was no reduction of Congo red
positive Aβ plaques. This finding further suggests that monocytic
cells reduce Aβ plaques by phagocytosis and emphasizes the
fact that monocytic cells should be drawn into the lesion site at
sufficient quantity.
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FIGURE 4 | Aβ affects monocytic cell viability in aggregation stage-dependent manner. LPS induced a pronounced production of reactive oxygen species
(ROS) (A, p < 0.05, n = 7). LPS increased cell proliferation/survival (B, p < 0.01, n = 8) while synthetic fAβ slightly reduced cell viability (B, p < 0.01, n = 8). When
monocytic cells were stimulated with freshly solubilized sAβ for 1 h, then washed and incubated another 23 h in the absence of Aβ to mimic the short stimulation
which induced calcium oscillations there was no reduction of cell viability (C, n = 8). sAβ did not change monocytic cell morphology as observed after LPS stimulation
(D) as pictured here 24 h after stimulation. Scale bar 20 µm. ∗p < 0.05, ∗∗p < 0.01.
DISCUSSION
First, the role of monocytic cells in AD pathology remains
unresolved although recent studies have provided insight into
this issue. CCR2, a chemokine receptor, was shown to be a
prerequisite for microglia accumulation in brain, to restrict
AD pathology (El Khoury et al., 2007). More specifically,
CCR2 deficiency in bone marrow cells exacerbated AD
pathology including mnesic deficits (Naert and Rivest, 2012).
This suggests CCR2 to play an important role for proper
monocyte/microglia function in AD. Mouse monocytes exist as
two main subsets: inflammatory CCR2+CX3CR1lowLy6C+/high
and resident CCR2−CX3CR1highLy6C−/low monocytes. These
monocyte subsets display different migration properties and
function in inflammation and steady state conditions (Auffray
et al., 2009). Although inflammatory monocytes are thought to
rapidly infiltrate into inflamed brain and participate in functions
such as inflammatory cytokine secretion and phagocytosis
(reviewed in Malm et al., 2010), there is recent evidence that
Ly6Clow patrolling monocytes also play a role in restricting
Aβ (Michaud et al., 2013). To be able to understand how
monocytic cells become activated and react in AD brain, it is
important to clarify their responses to specific stimuli. We aimed
to challenge the idea of Aβ acting as a classical pro-inflammatory
stimulus and investigated the effects of different forms of Aβ on
HSC-derived monocytic cells. As we show here, different forms
of Aβ contribute to separate cellular responses thereby possibly
regulating subcellular events and ultimately, cell functions
including phagocytosis.
We first aimed to decipher cellular responses of monocytic
cells to a known inflammatory stimulus. The most frequently
used model agent to study inflammatory cell activation is the
Gram-negative bacterial endotoxin LPS. It activates macrophages
and microglia through stimulating Toll-like receptor 4, although
recent studies suggest that alternative or even Toll-like receptor
4 independent signaling pathways are triggered when cells are
exposed to LPS (Kayagaki et al., 2013; Qu et al., 2015). We
detected a classical inflammatory cytokine and NO production,
well-known responses to LPS stimulation in cells of the
immune system. LPS has been shown to increase intracellular
calcium level in primary microglia cells, which is associated
with LPS-induced inflammatory activation such as secretion of
cytokines and NO. Moreover, increased intracellular calcium
level has been reported to be accompanied with decreased
responsiveness to external purinergic stimulation (Hoffmann
et al., 2003). In line with these previous observations, we detected
a minor increase in intracellular calcium levels in response
to LPS, which was accompanied with an immediate increase
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 December 2016 | Volume 10 | Article 279
Savchenko et al. Aβ Signaling in Monocytic Cells
FIGURE 5 | Monocytic cells retain their viability and phagocytic activity within native Aβ deposits ex vivo. The incubation of monocytic cells with native Aβ
deposits in hippocampal sections obtained from aged APdE9 mice did not affect cell viability (A, n = 8). Monocytic cells also retained their characteristics as
phagocytes since no difference in the percentage of CD68+ expressing cells (B, n = 6) or the expression level of CD68 (mean fluorescent intensity (MFI)) in single
cells were observed (C, n = 6). This was analyzed by flow cytometry after collecting the cells incubated on top of control (wt) and native Aβ (APdE9) mouse
hippocampal sections (D). Monocytic cells phagocytosed both diffuse and hard Aβ plaques (E). Monocytic cells gathered around vascular Aβ plaques but were not
observed to phagocytose them despite of high cell concentration (F). Scale bar 20 µm (F), 500 µm (E).
in cell protrusion motility. On the contrary, LPS-stimulation
did not reduce cellular response to purinergic stimulus in
our monocytic cell model. Instead, LPS reduced growth
factor—induced oscillatory calcium response. This indicates that
although the calcium signaling patterns induced by LPS are
somewhat similar in general, subtle cellular responses to LPS
may vary between different myeloid subtypes. This is probably
dependent on the cellular signaling profile of myeloid cell
subsets.
MCSF has been shown to induce calcium oscillations in a
microglia cell line. It was suggested further that MCSF induces
calcium-binding protein Iba-1 to play a role in membrane
ruffling and phagocytosis (Ohsawa et al., 2000). In line
with this, we detected MCSF to induce calcium oscillations.
HSC-derived monocytic cells also express Iba-1 as we have
shown earlier (Magga et al., 2012). In general, MCSF signaling
is a critical regulator of mononuclear phagocytic cell survival,
differentiation, development and chemotaxis (Nayak et al.,
2014).
Remarkably, our monocytic cells responded to freshly
solubilized synthetic Aβ by inducing persistent calcium
oscillations. Interestingly, oscillatory responses to Aβ
diminished and eventually vanished after Aβ solubilization
time-dependently, within 60–90 min after solubilization. Since
calcium oscillations decayed time-dependently in the course
of Aβ aggregation, we concluded that oscillatory calcium
responses are dependent on specific Aβ aggregation stage,
i.e., monomeric and/or small oligomeric Aβ. Aβ stimulus that
induced persistent calcium oscillations, induced a transient
production of anti-inflammatory cytokine but did not induce
any pro-inflammatory response in terms of ROS, NO or cytokine
production, nor reduced monocytic cell viability. Instead,
monocytic cells retained their phagocytic phenotype in native
Aβ-laden environment when all forms of Aβ were present.
Importantly, intrahippocampally transplanted monocytic cells
reduced Congo red positive fibrillar Aβ plaques from AD mouse
brain in vivo. On the contrary, microglial cells obtained from
aged AD mice have been shown to have defective Aβ clearance
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FIGURE 6 | Intrahippocampally transplanted monocytic cells reduce congophilic Aβ plaques in Alzheimer’s disease (AD) mouse model in vivo.
Monocytic cells obtained from green fluorescent protein (GFP) positive transgenic mouse were transplanted unilaterally into the hippocampus (A) using contralateral
vehicle-injection as a control. Hard Aβ plaques were identified with Congo red stain (B). Monocytic cells reduced congophilic Aβ plaques at the site of cell injection
(C, p < 0.01, n = 5). Scale bar 100 µm. DG, dentate gyrus. GFP and Congo red were determined from consequtive sections and pictured from the same site of the
hippocampus. ∗∗p < 0.01.
pathways (Hickman et al., 2008; von Bernhardi et al., 2015).
Moreover, an inverse correlation between pro-inflammatory
cytokine production and Aβ clearance was demonstrated to
microglia (Hickman et al., 2008).
In non-excitable cells, the main way to evoke oscillations
is through receptor-mediated activation of phospholipase C,
creation of diacylglycerol, and subsequent formation of second
messenger inositol 1,4,5-trisphosphate and periodical release of
calcium from endoplasmic reticulum calcium store. Oscillations
are usually accompanied with activation of store-operated
calcium channels and extracellular calcium influx to maintain
proper levels for calcium cycle. Oscillatory calcium signaling has
been associated with several cellular events including secretion,
metabolism, cell maturation and differentiation, chemotaxis
and induction of gene expression. Thus, oscillation-induced
cellular events range from seconds over hours to days. By
oscillations, a cell avoids toxic effects that arise from a constant
calcium elevation. As another benefit, oscillatory signals support
long-lasting cellular responses because of lower desensitization
of calcium-dependent responses that can occur during a
prolonged constant calcium signal, as reviewed in Parekh (2011).
Interestingly, in macrophages, oxidized LDL has been reported
to induce calcium oscillations which were suggested to promote
antiapoptotic pathways (Chen et al., 2009). In addition, calcium
oscillations are known to serve as cell survival signals in T-cells
(Harr and Distelhorst, 2010).
Disturbances in neuronal calcium signaling may play a crucial
role in the development of AD (Berridge, 2010), mostly in
terms of amyloid metabolism and action of presenilins. The role
of calcium signaling in glial cells or mononuclear phagocytes
is inadequately understood. In the adult brain, blood-derived
monocytes have the potential to repopulate myeloid niche
and calcium transients observed in engrafted monocytes are
very similar to that of surveillant resident microglia (Varvel
et al., 2012). Most of the studies concerning the actions of
mononuclear phagocytes however, are conducted withmicroglia.
There are many ligands which could induce calcium signaling
in microglia. These include chemokines, vasoactive peptides,
thrombin, growth factors and transmitters such as acetylcholine,
glutamate and noradrenaline (Möller, 2002; Kettenmann et al.,
2011). Several studies have shown elevation of intracellular
calcium in microglia/monocyte cells in response to Aβ (Korotzer
et al., 1995; Combs et al., 1999; Cui et al., 2002; Moon et al.,
2008; Sanz et al., 2009). While none of these studies reported
oscillatory calcium signaling, these studies suggested that Aβ-
induced calcium signaling promotes pro-inflammatory cellular
response which we did not observe after stimulation with any
type of synthetic or native Aβ deposits in our HSC-derived
monocytic cells. Besides cell type difference, this discrepancy
might also be explained by the fact that LPS is a frequent and
functionally significant contaminant in many commercial-grade
preparations of peptides or other substances commonly used
in research on microglial activation (Weinstein et al., 2008).
In addition, the aggregation and thus the effects of Aβ may
be different if Aβ is dissolved into organic solvent or aqueous
buffer.
Microglia may produce also ROS, reactive nitrogen
species and secreted cytokines in response to Aβ (Moon
et al., 2008; Querfurth and LaFerla, 2010). On the other
hand, calcium signaling pathways may interact with other
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cellular signaling systems such as ROS (Görlach et al., 2015),
indicating that disturbed calcium signaling may result in
altered ROS production and thus harmful activation of cells.
Importantly, perturbations in calcium signaling have been
reported in microglia obtained from AD patients. Receptor for
advanced glycation end products, a transmembrane receptor of
immunoglobulin family, and G-protein coupled formyl peptide
receptor found on microglia can both bind Aβ, resulting in
enhanced neuroinflammation and acceleration of AD pathology
via altered calcium signaling (Nayak et al., 2014). Similar
perturbations in cellular calcium were also obtained when
treating primary microglia with fibrillar Aβ: elevations of basal
calcium level accompanied with reduced amplitude to ligands
such as ATP indicating decreased activity of store-operated
calcium channels (McLarnon et al., 2005). In two-photon
imaging in vivo, cortical microglia were rather silent in terms
of their calcium signaling but they responded with large
calcium transients to focal damage of an individual neuron
in their vicinity (Eichhoff et al., 2011). Interestingly, calcium
transients evoked by minor cell or tissue damages in the vicinity
of microglial cells may be especially frequent near plaques,
as reflected by profound hyperactivity of plaque-associated
microglia (Brawek et al., 2014). Similar persistent calcium
oscillations in response to Aβ what we observed have been
previously reported in astrocytes where they were accompanied
with neurotoxic effects in hippocampal coculture (Abramov
et al., 2003). However, neurotoxicity was studied within 24 h
of Aβ incubation, while immediate cellular effects other than
calcium signaling were not assessed. In summary, Aβ-induced
calcium signals are thought to be associated with harmful
activation of cells by evoking pro-inflammatory pathways, which
are generally thought to be associated with neurotoxicity. In
the present study, we did not observe sAβ-evoked calcium
oscillations to induce activation of pro-inflammatory pathways
in monocytic cells.
Activation of metabotropic glutamate receptor mGlu5 is
known to induce calcium oscillations (Nash et al., 2001).
mGlu5 was found to negatively regulate the release of microglia-
associated inflammatory factors and related neurotoxicity
(Byrnes et al., 2009; Farso et al., 2009). There is some evidence
that mGlu5 could function as a receptor or co-receptor for
Aβ (Kumar et al., 2015), although Aβ-mGlu5 interaction
specifically in microglia is not known. It remains to be
clarified in future experiments whether sAβ-induced calcium
oscillations we observed in monocytic cells: (i) enquire
mGlu5 receptors; (ii) serve as a signal to induce several
anti-inflammatory pathways; and (iii) prime monocytic cells for
phagocytosis.
It has been reported on astrocytes that effects of Aβ and
pro-inflammatory factors on the cytosolic calcium dynamics
are different. mGluR-mediated calcium signaling as well as
store-operated calcium entry were augmented in response to
Aβ while opposite changes were observed when astrocytes were
treated with pro-inflammatory agents TNFα, IL1β and LPS
(Ronco et al., 2014). In line with our present study, it could
be concluded that Aβ cannot be regarded as a traditional
pro-inflammatory agent in monocytic cells; to the contrary, Aβ
employs alternative pathways to affect the state and function of
these cells.
CONCLUSION
In this study, we show that Aβ induces specific calcium signaling
in HSC-derived monocytic cells which does not lead to harmful
inflammatory activation nor reduces viability of these cells. To
our knowledge, this is the first study to show an oscillatory signal
in response to sAβ in mononuclear phagocytes. When further
characterized, this signaling pathway may introduce a novel
therapeutic target in mononuclear phagocytic cells. Although
its purpose is currently unknown, this signal may promote
phagocytosis or prime the cells to encounter the possible threat
of coming excessive Aβ load.
Our study also suggests that HSC-derived monocytic cells
retain their viability and function in the presence of native Aβ
deposits while reducing Aβ burden even by removal of hard Aβ
plaques. This further affirms that HSC-derived monocytic cells
could possibly be used as cell-based therapeutics in the treatment
of AD. Since these cells could be genetically modified before their
differentiation into monocytic cells, the further challenge is to
program the cells to enhance their proper infiltration into the
brain parenchyma.
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